AOTI Inc. announced today that its fully owned USA-operating subsidiary, Advanced Oxygen Therapy Inc., has recently opened a New York City Office in Yonkers, New York to support the ever-increasing usage of its unique Topical Wound Oxygen (TWO2) homecare therapy. This new East Coast location has also been approved by the Accreditation Commission for Health Care (ACHC) under the company’s DMEPOS accreditation for Home/Durable Medical Equipment Services.
OCEANSIDE, Calif., May 10, 2017 /PRNewswire/ — AOTI Inc. announced today that its revolutionary patented Topical Wound Oxygen (TWO2) homecare therapy has received a Strong GRADE 1B Treatment recommendation in the European Wound Management Association (EWMA) guidance document, entitled: Use of oxygen therapies in wound healing, with special focus on topical and hyperbaric oxygen treatment, published […]
Oceanside, California USA, Apr 3 – AOTI Inc. announced today that over 1,000,000 home treatments have been provided with its revolutionary patented Topical Wound Oxygen (TWO2) therapy. “This is a momentous milestone for our company and a testament to the clinical efficacy of TWO2 therapy, we are delighted to have helped heal the wounds of so […]
Oceanside, California USA, Feb 17 – AOTI Inc. announced today that it’s fully owned USA operating subsidiary, Advanced Oxygen Therapy Inc., has been awarded DMEPOS accreditation for Home/Durable Medical Equipment Services by the Accreditation Commission for Health Care (ACHC) Achieving accreditation is a process where healthcare organizations demonstrate compliance with national standards. Accreditation by ACHC […]
Oceanside, California USA, Feb 14 – AOTI Inc. announced today that it will again be providing an expansive Clinical Education program at the Desert Foot conference, East and Midwest Podiatric Residency summits, which are the leading conferences focused on the Veterans Administration and other Federal Government segments. “These three congresses provide an unparalleled opportunity to educate […]
Oceanside, California USA, Aug 16 – AOTI Inc. announced today the U.S. Patent and Trademark Office have granted its Patent Application No. 14/150,178 – CONTROLLER FOR AN EXTREMITY HYPERBARIC DEVICE that will now issue as U.S. Patent No. 9,421,147. This is the 24th global patent to be awarded to date on AOTI’s revolutionary Topical Wound Oxygen […]
